17556-22-8

Usage

Uses

Used in Pharmaceutical Industry:
6,7-Dichloro-2-tetralone is utilized as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new medications due to its chemical properties and reactivity.
Used in Agrochemical Industry:
In the agrochemical sector, 6,7-Dichloro-2-tetralone serves as a key intermediate, playing a crucial role in the production of agrochemicals that are vital for agricultural applications.
Used in Fragrance and Flavor Industry:
6,7-Dichloro-2-tetralone is employed in the creation of fragrances and flavors, capitalizing on its chemical structure to produce desired scents and tastes in various consumer products.
Used in Medicinal Chemistry Research:
6,7-Dichloro-2-tetralone is used as a building block in medicinal chemistry for the design and synthesis of novel drugs, leveraging its potential therapeutic properties and chemical versatility.
Used in Scientific Research:
6,7-Dichloro-2-tetralone is a subject of interest in scientific research due to its pharmacological properties, with potential applications in the discovery and development of new therapeutic agents.

Upstream product

• 68755-31-7 5,6-dichloro-2,3-dihydro-1H-inden-1-one 

Downstream Products

• 23417-70-1 6,7-Dichlor-2-naphthylamin 

Relevant academic research and scientific papers

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

Heteroannulation process

A heteroannulation process for preparing piperidones and tetrahydropyridones by reacting an appropriately substituted enamine with an acryloyl derivative wherein a leaving group occupies the carbonyl; a process for cleaving a 1-phenylethyl group from an a